Allurion Technologies Holdings Inc. has announced a transaction to exchange all of its outstanding debt and obligations under its Revenue Interest Financing Agreements for shares of newly created Series B Convertible Preferred Stock. This exchange would result in the company being debt-free. The Series B Preferred Stock will be convertible into shares of common stock under certain circumstances. This move is part of Allurion's strategy to strengthen its financial position as it seeks FDA approval for its Allurion Smart Capsule.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251111733050) on November 11, 2025, and is solely responsible for the information contained therein.